BlockBeats News: On January 15, Tom Lee, chairman of BitMine, stated in an interview with 3PROTV that Ethereum founder Vitalik Buterin and OpenAI CEO Sam Altman are expected to attend today's (January 15) annual shareholders' meeting. The meeting will vote on a proposal to increase the company's authorized share capital from 500 million to 50 billion shares. Tom Lee emphasized that if the proposal is not approved, the company will not be able to issue new shares to purchase more Ethereum or make acquisitions. In response to concerns about dilution, he stated that the company has never issued shares at a price below its net asset value. Additionally, BitMine will present its 2026 development roadmap at the meeting, including growth sources beyond staking rewards, and will reveal potential future acquisitions of other crypto treasury companies.
Vitalik Buterin and Sam Altman to Attend BitMine Annual Shareholders Meeting
KuCoinFlashShare
Summary
Ethereum-related news emerged as BitMine CEO Tom Lee told 3PROTV that Vitalik Buterin and Sam Altman will attend the company's annual shareholders meeting on January 15, 2026. The meeting will vote on increasing the authorized share count from 500 million to 50 billion. Without shareholder approval, BitMine cannot issue new shares to purchase Ethereum or make acquisitions. Lee stated that the company has never issued shares below net asset value and will reveal a 2026 growth plan, which may include on-chain, news-driven acquisitions of cryptocurrency treasury firms.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.